FBLG (FibroBiologics, Inc. Common Stock) Stock Financials & Earnings

FBLGFibroBiologics, Inc. Common Stock

Mkt Cap$17M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$19M

EPS (TTM)-$0.44

Free Cash Flow (TTM)-$17M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$2M
Q2 23	$0	$0	-$2M
Q3 23	$0	$0	-$2M
Q4 23	$0	$0	-$2M
Q1 24	$0	$0	-$3M
Q2 24	$0	$0	-$3M
Q3 24	$0	$0	-$3M
Q4 24	$0	$0	-$4M
Q1 25	$0	$0	-$5M
Q2 25	$0	$0	-$4M
Q3 25	$0	-$231K	-$5M
Q4 25	$0	-$234K	-$3M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$478K	$2M	—
Q2 23	$547K	$2M	—
Q3 23	$571K	$1M	—
Q4 23	$773K	$2M	—
Q1 24	$960K	$2M	—
Q2 24	$975K	$2M	—
Q3 24	$1M	$2M	—
Q4 24	$1M	$2M	—
Q1 25	$2M	$3M	—
Q2 25	$2M	$2M	—
Q3 25	$3M	—	$2M
Q4 25	$797K	$4M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$0	$0	$0
Q2 23	$11M	$0	$11M
Q3 23	$11M	$0	$11M
Q4 23	$9M	$0	$9M
Q1 24	$8M	$0	$8M
Q2 24	$6M	$0	$6M
Q3 24	$8M	$0	$8M
Q4 24	$14M	$0	$14M
Q1 25	$9M	$0	$9M
Q2 25	$9M	$0	$9M
Q3 25	$5M	$0	$5M
Q4 25	$5M	$0	$5M

Shares Outstanding

Revenue Per Employee

Revenue / Employee